Unfractionated heparin dosing nomograms: Road maps to where?

Research output: Contribution to journalArticle

6 Scopus citations


Weight-adjusted nomograms have been a significant advance in the use of unfractionated heparin (UFH). Clinical trials have demonstrated the ability of weight-adjusted nomograms to achieve a therapeutic activated partial thromboplastin time (aPTT) more rapidly than with standard UFH dosing. Despite this advantage, a significant number of patients have subtherapeutic and supratherapeutic aPTTs. Real-world experiences also corroborate the inability to keep UFH therapeutic with the use of nomograms. Despite the limitations of UFH nomograms, they have been used in several different types of venous and arterial thrombosis treatment settings. Unfortunately, these nomograms are not all consistent and require a considerable amount of time for training health care professionals on their use in order to limit the potential for medication errors. Although UFH nomograms have provided advancement over standard UFH dosing, their limitations still generate the desire for a more predictable anticoagulant.

Original languageEnglish (US)
Pages (from-to)142S-145S
Issue number8 II
StatePublished - Aug 2004


  • Activated partial thromboplastin time
  • Nomograms
  • Standard dosing
  • Thrombosis
  • Unfractionated heparin
  • Weight-based dosing

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Unfractionated heparin dosing nomograms: Road maps to where?'. Together they form a unique fingerprint.

  • Cite this